Related Concept Videos
02:16Light Acquisition
9.6K
In order to produce glucose, plants need to capture sufficient light energy. Many modern plants have evolved leaves specialized for light acquisition. Leaves can be only millimeters in width or tens of meters wide, depending on the environment. Due to competition for sunlight, evolution has driven the evolution of increasingly larger leaves and taller plants, to avoid shading by their neighbors with contaminant elaboration of root architecture and mechanisms to transport water and nutrients.
9.6K
02:34Water and Mineral Acquisition
35.7K
Specialized tissues in plant roots have evolved to capture water, minerals, and some ions from the soil. Roots exhibit a variety of branching patterns that facilitate this process. The outermost root cells have specialized structures called root hairs that increase the root surface, thus increasing soil contact. Water can passively cross into roots, as the concentration of water in the soil is higher than that of the root tissue. Minerals, in contrast, are actively transported into root cells.
35.7K
02:20Routes of Persuasion
68.7K
Persuasion is the process of changing our attitude toward something based on some kind of communication. Much of the persuasion we experience comes from outside forces. How do people convince others to change their attitudes, beliefs, and behaviors? What communications do you receive that attempt to persuade you to change your attitudes, beliefs, and behaviors?
68.7K
02:11The Roles of Bacteria and Fungi in Plant Nutrition
47.3K
Plants have the impressive ability to create their own food through photosynthesis. However, plants often require assistance from organisms in the soil to acquire the nutrients they need to function correctly. Both bacteria and fungi have evolved symbiotic relationships with plants that help the species to thrive in a wide variety of environments.
47.3K
03:21Genome Size and the Evolution of New Genes
9.1K
While every living organism has a genome of some kind (be it RNA, or DNA), there is considerable variation in the sizes of these blueprints. One major factor that impacts genome size is whether the organism is prokaryotic or eukaryotic. In prokaryotes, the genome contains little to no non-coding sequence, such that genes are tightly clustered in groups or operons sequentially along the chromosome. Conversely, the genes in eukaryotes are punctuated by long stretches of non-coding sequence.
9.1K
03:50The Scientific Method
66.0K
Chemistry is an empirical science. Scientists often pose questions to understand the chemistry in everyday life and seek answers to these questions. To achieve this, scientists follow a definitive series of steps that together make up the Scientific Method. This approach involves making observations, asking questions, building a hypothesis, conducting experiments, analyzing results, and forming a conclusion.
66.0K
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same journal
Brain Network Connectivity Predicts Survival in Diffuse Midline Glioma.
Cancer discovery·2026
Same journal
First-in-human testing of a mutant KRAS vaccine for pancreatic cancer interception in high-risk cohorts.
Cancer discovery·2026
Same journal
CDK8 Inhibition Releases the Muscle Differentiation Block in Fusion-driven Alveolar Rhabdomyosarcoma.
Cancer discovery·2026
Related Experiment Video
Updated: Jan 30, 2026
07:46
Data Acquisition Protocol for Determining Embedded Sensitivity Functions
Published on: April 20, 2016
6.5K
Summary
Major pharmaceutical companies acquired biotech firms, but this is unlikely to change cancer drug development focus. Experts anticipate these deals may not be profitable and could lead to increased drug prices.
Area of Science:
- Oncology
- Pharmaceutical Industry Analysis
Background:
- Recent high-profile acquisitions include Bristol-Myers Squibb's purchase of Celgene and Eli Lilly's acquisition of Loxo Oncology.
- These strategic moves by major pharmaceutical players signal significant consolidation within the oncology sector.
Discussion:
- The acquisitions are not expected to fundamentally alter the trajectory of cancer drug development pipelines.
- Industry experts express skepticism regarding the long-term profitability of these mergers and acquisitions.
Key Insights:
- Despite substantial investment, the profitability of these acquisitions remains uncertain.
- A potential consequence of these deals is an anticipated short-term increase in cancer drug pricing.
Outlook:
- The long-term financial viability and strategic impact of these acquisitions require further monitoring.
- Future market dynamics will be influenced by the integration of acquired assets and the success of ongoing research and development efforts.